Navigation Links
Severe gestational hypertension may protect against testicular cancer
Date:10/29/2008

PHILADELPHIA Women who experience severe gestational hypertension may give birth to boys at lower risk for testicular cancer, although the exact reasons why are still unclear, according to a paper published in the November 1, 2008, issue of Cancer Research, a journal of the American Association for Cancer Research.

Andreas Pettersson, M.D., a doctoral student at Karolinska Institute in Sweden, said the protective effect of gestational hypertension may be due to the hormones that are released when a placenta malfunctions.

"Ironically, a malfunctioning placenta may lower the risk," said Pettersson. "One possible reason is that estrogens are lower in pregnancies that develop severe gestational hypertension or preeclampsia, and this lack of estrogens may lower the risk of testicular cancer."

Pettersson and colleagues observed 293 cases of germ-cell testicular cancer in the Swedish Cancer Register and 861 controls in the Swedish Medical Birth Register. They extracted data on maternal and pregnancy characteristics such as gestational hypertension, proteinuria, anemia and glucoseuria.

If women experienced severe gestational hypertension, their male offspring were 71 percent less likely to develop testicular cancer than those women who experienced no hypertension. If the gestational hypertension was mild, there was a 62 percent increased risk of testicular cancer.

Beyond decreased estrogen, severe gestational hypertension and preeclampsia increases the level of human Chorionic Gonadotropin, another pregnancy-related hormone, which may also have a protective effect against testicular cancer.

Pettersson said that these findings add knowledge to the mechanisms behind testicular cancer, but he cautioned against reverse thinking.

"This study does not suggest that a woman who does not have gestational hypertension is going to give birth to a boy who is at increased risk for testicular cancer," said Pettersson.


'/>"/>

Contact: Jeremy Moore
Jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Related biology news :

1. Franklin Square to study airway bypass procedure for severe emphysema
2. Severe climate change costs forecast for Pennsylvania, N.C., Tennessee, N.D.
3. Cortisol and fatty liver: Researchers find cause of severe metabolic disorders
4. Toxoplasmosis found more severe in Brazil compared to Europe
5. Treatment corrects severe insulin imbalance in animal studies
6. UIC researchers make promising finding in severe lung disease
7. Climate change could severely impact Californias unique native plants
8. Hyperviscous fluids: Better treatment for severe blood loss
9. Impoverished areas of Africa and Asia face severe crop losses from climate change in 20 years
10. Severe asthma may be a different form of the disease
11. Yale discovery suggests protein may play a role in severe asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2020)... ... June 02, 2020 , ... ... software developer and solutions provider, today reported that the implementation of browser-based, ... compliance by 100%, resulting in greater efficiency for global biotechnology company, bioMérieux. ...
(Date:5/28/2020)... ... May 27, 2020 , ... CrucialTrak, a global designer ... New Jersey-based Critical Environments Group (CEG) to market and sell its complete line of ... center and IT environment infrastructure optimization solutions . , Brett Mason, CrucialTrak’s ...
(Date:5/28/2020)... ... May 28, 2020 , ... ... adjunct liquefaction: AMYLEX® 6T. The innovative enzyme enables numerous business gains for ... with locally-sourced raw materials, improve productivity, maximize yield, ensure consistent quality and ...
Breaking Biology News(10 mins):
(Date:6/28/2020)... (PRWEB) , ... June 25, 2020 , ... The Indoor ... launch of Safe Space™ for businesses of all types to ensure cleanliness, distancing and ... , A Safe Space™ enabled business will provide a health performance index ...
(Date:6/28/2020)... (PRWEB) , ... June 25, 2020 , ... ... to advance photodynamic therapy for treating cancer, today announced the company has entered ... (“Roswell Park”). The agreement provides Lumeda globally exclusive rights to Roswell Park ...
(Date:6/23/2020)... ... June 23, 2020 , ... Kerafast Inc. , ... today announced the availability of the Delta-G-VSV Pseudotyping System for coronavirus research applications. ... studies of SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just biosafety level ...
(Date:6/23/2020)... ... June 22, 2020 , ... Regen ... special offer. This includes buy three, get the fourth unit free with no ... Amniotic derived exosomes, known as exosomes, have been a game changer for regenerative ...
Breaking Biology Technology: